Current best practice in Venesection treatment in haemochromatosis
Venesection treatment in haemochromatosis – current best practice from the BSG/BASL Special Interest Group
Venesection, otherwise known as therapeutic phlebotomy has been the primary treatment offered to patients with haemochromatosis for more than half a century. It is generally well-tolerated and has been demonstrated to reduce many of the serious long-term consequences of the condition but there is a lack of robust research to guide the optimal frequency, timing and treatment targets for venesection treatment in haemochromatosis.
A multidisciplinary team of professional members of the British Society of Gastroenterology/British Association for the Study of the Liver Haemochromatosis Special Interest Group describes current best practice and presents a framework and recommendations for treatment and management of venesection side effects and complications.
Click here to download the paper